Motiur Rahman Litu, PBC news: World-renowned pharmaceutical company Pfizer and German-based Bioentech company have announced the discovery of Covid-19 vaccine with 90% success on Monday, November 9th 2020. The discovery of the Covid-19 vaccine will revitalize the stagnant world and return to normal life, claims German-based Bioentech CEO Dr. Shaheen.
Turkish descent Muslim couple Shaheen-Turesi, the founder of Bioentech company was fully responsible for discovery of the Covid-19 vaccine. The company Founded just a few years ago has now become worth of 21 billion dollars.
Only two years ago Dr. Ugur Sahin the founder of BioNtech said his company might be able to use its so-called messenger RNA technology to rapidly develop a vaccine in the event of a global pandemic. Covid-19 viruses were not yet even exist at that time. Now the time of Corona virus Pandemic he has proven his company’s work.
Pfizer and Biotech were working together since 2018, producing various types of vaccines but nothing was more breakthrough than Covid-19 vaccines.
Dr. Sahin, 55, was born in Iskenderun, Turkey. When he was 4, his family moved to Cologne, Germany, where his parents worked at a Ford factory. He grew up wanting to be a doctor, and became a physician at the University of Cologne. In 1993, he earned a doctorate from the university for his work on immunotherapy in tumor cells.
Early in his career, he met Dr. Türeci. She had early hopes to become a nun and ultimately wound up studying medicine. Dr. Türeci, now 53 and the chief medical officer of BioNTech, was born in Germany, the daughter of a Turkish physician who immigrated from Istanbul. On the day they were married, Dr. Sahin and Dr. Türeci returned to the lab after the ceremony. The pair were initially focused on research and teaching, including at the University of Zurich, where Dr. Sahin worked in the lab of Rolf Zinkernagel, who won the 1996 Nobel Prize in medicine.
In 2001, Dr. Sahin and Dr. Türeci founded Ganymed Pharmaceuticals, which developed drugs to treat cancer using monoclonal antibodies.
After several years they founded BioNTech as well, looking to use a wider range of technologies, including messenger RNA, to treat cancer cells.
Even before the pandemic, BioNTech was gaining momentum. The company raised hundreds of millions of dollars and now has more than 1,800 people on staff, with offices in Berlin, other German cities and Cambridge, Mass. In 2018, it began its partnership with Pfizer. Last year, the Bill & Melinda Gates Foundation invested $55 million to fund its work treating H.I.V. and tuberculosis.
In 2019, Dr. Sahin was awarded the Mustafa Prize, a biennial Iranian prize for Muslims in science and technology.